BCLC staging
The liver-cancer staging system that combines tumour size, liver function and fitness to recommend treatment: ablation or surgery, transplant, TACE, or drugs.
Barcelona Clinic Liver Cancer stages 0/A (very early/early: ablation, resection, transplant), B (intermediate: TACE, or systemic therapy for high burden), C (advanced: systemic therapy) and D (terminal). The 2022 update introduced treatment-stage migration and systemic therapy for some BCLC-B patients. Used in guidelines worldwide and as a trial-eligibility framework.
Pages like this
not linked directly; found by shared links- TermTARE / SIRT (radioembolisation with yttrium-90)
Shares Portal vein tumour thrombus (macrovascular invasion), TACE (transarterial chemoembolisation), Transarterial chemoembolisation (TACE), Hepatocellular carcinoma.
- TermHepatectomy (liver resection)
Shares Child-Pugh score, Downstaging and conversion therapy, Thermal ablation (RFA, microwave, cryo), Hepatocellular carcinoma.
- TermLiver-directed therapy (TACE, TARE, HAI, ablation)
Shares TACE (transarterial chemoembolisation), Transarterial chemoembolisation (TACE), Thermal ablation (RFA, microwave, cryo), Hepatocellular carcinoma.
- TermHepatotoxicity (liver enzyme elevation)
Shares Cirrhosis, Child-Pugh score.
- PersonSung-Gyu Lee
Shares Liver transplantation for cancer (Milan criteria and beyond), Hepatocellular carcinoma.
- IdeaImmunotherapy downstaging to transplant with a safe washout
Shares Liver transplantation for cancer (Milan criteria and beyond), Hepatocellular carcinoma.
- CompanyBoston Scientific
Shares Transarterial chemoembolisation (TACE), Hepatocellular carcinoma.
- TrialEMERALD-1
Shares Transarterial chemoembolisation (TACE), Hepatocellular carcinoma.